Literature DB >> 10543972

Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.

Z F Kanyo1, K M Pan, R A Williamson, D R Burton, S B Prusiner, R J Fletterick, F E Cohen.   

Abstract

The X-ray crystallographic structures of the anti-Syrian hamster prion protein (SHaPrP) monoclonal Fab 3F4 alone, as well as the complex with its cognate peptide epitope (SHaPrP 104-113), have been determined to atomic resolution. The conformation of the decapeptide is an Omega-loop. There are substantial alterations in the antibody combining region upon epitope binding. The peptide binds in a U-shaped groove on the Fab surface, with the two specificity determinants, Met109 and Met112, penetrating deeply into separate hydrophobic cavities formed by the heavy and light chain complementarity-determining regions. In addition to the numerous contacts between the Fab and the peptide, two intrapeptide hydrogen bonds are observed, perhaps indicating the structure bound to the Fab exists transiently in solution. This provides the first structural information on a portion of the PrP N-terminal region observed to be flexible in the NMR studies of SHPrP 90-231, SHaPrP 29-231 and mouse PrP 23-231. Antibody characterization of the antigenic surfaces of PrPC and PrPSc identifies this flexible region as a component of the conformational rearrangement that is an essential feature of prion disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543972     DOI: 10.1006/jmbi.1999.3193

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.

Authors:  E Leclerc; D Peretz; H Ball; H Sakurai; G Legname; A Serban; S B Prusiner; D R Burton; R A Williamson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Electron crystallography of the scrapie prion protein complexed with heavy metals.

Authors:  Holger Wille; Cédric Govaerts; Alexander Borovinskiy; Diane Latawiec; Kenneth H Downing; Fred E Cohen; Stanley B Prusiner
Journal:  Arch Biochem Biophys       Date:  2007-08-23       Impact factor: 4.013

3.  Allosteric control of antibody-prion recognition through oxidation of a disulfide bond between the CH and CL chains.

Authors:  Jun Zhao; Ruth Nussinov; Buyong Ma
Journal:  Protein Eng Des Sel       Date:  2016-11-29       Impact factor: 1.650

4.  Characterization of conformation-dependent prion protein epitopes.

Authors:  Hae-Eun Kang; Chu Chun Weng; Eri Saijo; Vicki Saylor; Jifeng Bian; Sehun Kim; Laylaa Ramos; Rachel Angers; Katie Langenfeld; Vadim Khaychuk; Carla Calvi; Jason Bartz; Nora Hunter; Glenn C Telling
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

5.  Mapping the early steps in the pH-induced conformational conversion of the prion protein.

Authors:  D O Alonso; S J DeArmond; F E Cohen; V Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 6.  Antibody-Mediated Catalysis in Infection and Immunity.

Authors:  Anthony Bowen; Maggie Wear; Arturo Casadevall
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

7.  Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers.

Authors:  R M Barron; V Thomson; E Jamieson; D W Melton; J Ironside; R Will; J C Manson
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

8.  Disulfide mapping reveals the domain swapping as the crucial process of the structural conversion of prion protein.

Authors:  Iva Hafner-Bratkovič; Roman Jerala
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

9.  Vitamin D 2 interacts with Human PrP(c) (90-231) and breaks PrP(c) oligomerization in vitro.

Authors:  Midori Suenaga; Yusuke Hiramoto; Yoichi Matsunaga
Journal:  Prion       Date:  2013-07-15       Impact factor: 3.931

Review 10.  Conformational selection in amyloid-based immunotherapy: Survey of crystal structures of antibody-amyloid complexes.

Authors:  Buyong Ma; Jun Zhao; Ruth Nussinov
Journal:  Biochim Biophys Acta       Date:  2016-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.